These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7897755)

  • 1. Fatal lorcainide poisoning.
    Evers J; Büttner-Belz U
    J Toxicol Clin Toxicol; 1995; 33(2):157-9. PubMed ID: 7897755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lorcainide in patients with refractory ventricular tachyarrhythmia.
    Chesnie B; Lampert S; Podrid P; Lown B
    J Am Coll Cardiol; 1984 Jun; 3(6):1531-9. PubMed ID: 6715710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and simple method for determination of lorcainide, a new antiarrhythmic drug, and its major metabolite, norlorcainide, by high-performance liquid chromatography.
    Simon V; Somani P
    J Chromatogr; 1982 Sep; 231(2):478-84. PubMed ID: 7130327
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiarrhythmic effect of lorcainide in patients taking digoxin.
    Giardina EG; Raby K; Saroff AL; Louie-Chu M
    J Clin Pharmacol; 1987; 27(5):378-83. PubMed ID: 3693581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term lorcainide therapy guided by electrophysiology studies.
    Somberg J; Butler B; Flowers D; Tepper D; Torres V
    Acta Cardiol; 1985; 40(6):621-36. PubMed ID: 3879419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of lorcainide, a new antiarrhythmic drug, in patients with cardiac rhythm disorders.
    Somani P
    Am J Cardiol; 1981 Jul; 48(1):157-63. PubMed ID: 7246437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lorcainide for the treatment of refractory ventricular tachycardia: clinical and electrophysiologic results.
    Hanyok JJ; Kluger J; Chow MS; Fieldman A
    J Clin Pharmacol; 1987 Apr; 27(4):278-82. PubMed ID: 3680584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic effect of lorcainide during chronic treatment.
    Meinertz T; Kasper W; Kersting F; Bechtold H; Just H; Jähnchen E
    Arzneimittelforschung; 1980; 30(9):1593-5. PubMed ID: 7193031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HPLC method for determination of lorcainide hydrochloride in human serum].
    Luo X; Zeng FD
    Yao Xue Xue Bao; 1995; 30(8):605-9. PubMed ID: 8571780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the electrophysiologic effects of intravenous and oral lorcainide in patients with recurrent ventricular tachycardia.
    Echt DS; Mitchell LB; Kates RE; Winkle RA
    Circulation; 1983 Aug; 68(2):392-9. PubMed ID: 6861314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use and limitations of deuterated lorcainide in metabolism and pharmacokinetic studies.
    Gelijkens CF; Van Peer A; Lenoir H; Knaeps A; Woestenborghs R; Heykants J
    Biomed Mass Spectrom; 1985 Jan; 12(1):38-42. PubMed ID: 3157409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lorcainide in the prophylaxis of ventricular arrhythmias in acute myocardial infarction.
    Leinonen H; Heikkilä J; Sundberg S; Gordin A
    Ann Clin Res; 1984; 16(1):18-22. PubMed ID: 6378045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological characteristics of lorcainide, a new antiarrhythmic drug.
    Solti F; Czakó E; Szatmáry L
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):26-9. PubMed ID: 3957486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics of the initiation of antiarrhythmic therapy with lorcainide.
    Winkle RA; Keefe DL; Rodriguez I; Kates RE
    Am J Cardiol; 1984 Feb; 53(4):544-51. PubMed ID: 6198895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic lorcainide therapy for symptomatic premature ventricular complexes: efficacy, pharmacokinetics and evidence for norlorcainide antiarrhythmic effect.
    Mead RH; Keefe DL; Kates RE; Winkle RA
    Am J Cardiol; 1985 Jan; 55(1):72-8. PubMed ID: 2578245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of enzyme induction on the disposition of lorcainide in rats following intravenous and oral administration.
    Plänitz V; Jähnchen E
    Arzneimittelforschung; 1984; 34(6):669-71. PubMed ID: 6541487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lorcainide (R 15 889), a first review.
    Amery WK; Heykants JJ; Xhonneux R; Towse G; Oettel P; Gough DA; Janssen PA
    Acta Cardiol; 1981; 36(3):207-34. PubMed ID: 7020313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prehepatic and hepatic first-pass metabolism of lorcainide in rats.
    Plänitz V; Grönniger J; Jähnchen E
    Arzneimittelforschung; 1985; 35(6):923-6. PubMed ID: 4026917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of intravenous lorcainide with lidocaine for acute therapy of complex ventricular arrhythmias: results of a randomized study with crossover option.
    Anderson JL; Anastasiou-Nana M; Lutz JR; Writer SL
    J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):333-41. PubMed ID: 3881497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of lorcainide.
    Keefe DL
    Am J Cardiol; 1984 Aug; 54(4):18B-21B. PubMed ID: 6465043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.